Multiepitope Polypeptide of the HIV-1 Envelope Induces Neutralizing Monoclonal Antibodies against V3 Loop
- 1 March 1994
- journal article
- research article
- Published by Mary Ann Liebert Inc in AIDS Research and Human Retroviruses
- Vol. 10 (3), 235-243
- https://doi.org/10.1089/aid.1994.10.235
Abstract
A gene encoding a multiepitope polypeptide (MEP) has been synthesized. It contains the information for (1) an 11-amino acid (aa) epitope from the C1 region of gp120 of HIV-1 and (2) 3 epitopes of 15 amino acids each, from the central part of the V3 loop of isolates MN, SC, and WMJII. These four segments are linked by the short spacer peptide AGGGA. This gene was cloned in a plasmid vector and expressed in Escherichia coli as a fusion product with a 62-aa fragment of human IL-2. The recombinant protein TAB1 was purified by washed pellet procedures and reversed-phase HPLC. TAB1 was recognized in ELISAs by 25 of 27 sera from seropositive individuals. Mice were immunized and several hybridomas were obtained. Two of them secrete monoclonal antibodies that react with synthetic peptides from isolates MN, WMJI, WMJIII, and SC with an affinity constant in the range of 108 M-1. They also recognized peptides from isolates SF2 and WMJII, but at much lower affinity. The results obtained from peptide ELISAs indicate that the putative epitope recognized by these MAbs lies within the sequence IHIGPGRAFYT. Classic neutralization assays demonstrated that MAb 2C4 neutralizes 50% of the MN isolate at 0.6 μg/ml but fails to neutralize IIIB and SF2 strains. The presence of antibodies directed against every one of the component peptides in the sera of rabbits immunized with TAB1 was also documented.Keywords
This publication has 36 references indexed in Scilit:
- Synergy Between Human Monoclonal Antibodies to HIV Extends Their Effective Biologic Activity Against Homologous and Divergent StrainsAIDS Research and Human Retroviruses, 1992
- High Prevalence of Antibodies to the gp120 V3 Region Principal Neutralizing Determinant of HIV-1MNin Sera from Africa and the AmericasAIDS Research and Human Retroviruses, 1991
- Antibody Responses of Chimpanzees Immunized with Synthetic Peptides Corresponding to Full-Length V3 Hypervariable Loops of HIV-1 Envelope GlycoproteinsAIDS Research and Human Retroviruses, 1991
- HIV-1 testing: product development strategiesTrends in Biotechnology, 1990
- Conserved Sequence and Structural Elements in the HIV-1 Principal Neutralizing DeterminantScience, 1990
- Expression of HIV-1 gp120 and Human Soluble CD4 by Recombinant Baculoviruses and their Interaction In VitroAIDS Research and Human Retroviruses, 1990
- Nucleotide Sequences ofgagandenvGenes of a Japanese Isolate of HIV-1 and Their Expression in BacteriaAIDS Research and Human Retroviruses, 1989
- AIDS virus env Protein Expressed from a Recombinant Vaccinia VirusNature Biotechnology, 1986
- HTLV-III env gene products synthesized in E. coli are recognized by antibodies present in the sera of AIDS patientsCell, 1985
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970